Vestibular migraine (VM) is a common cause of recurrent episodic vertigo, and it is associated with significant disability from recurrent vestibular and migraine symptoms. While there are a number of standard preventive treatments, their effectiveness is quite variable, and new treatments which target calcitonin gene-related peptide (CGRP) have been identified as potential treatments....
✦ The floor
Discussion
Signed responses from readers of the wire.
CGRP-targeted therapies show emerging promise for vestibular migraine; audiologists and vestibular specialists should be aware of this evolving treatment landscape when collaborating with neurology, though prescribing decisions remain with physicians.
A systematic review of CGRP-targeted therapies for vestibular migraine marks a significant step toward evidence-based treatment guidance for a condition that audiologists and vestibular specialists frequently co-manage.
- 01Systematic review covers both conventional and CGRP-targeted therapies for vestibular migraine.
- 02CGRP-targeted agents represent a newer pharmacological class being evaluated for vestibular migraine management.
- 03Diagnostic criteria and clinical workup approaches for vestibular migraine are summarized.
- 04Review published in Frontiers in Neurology, a peer-reviewed open-access journal.
- 05Findings may help standardize multidisciplinary management of vestibular migraine.
CGRP-targeted therapies are effective or beneficial in the management of vestibular migraine.
studypartially supportedConventional therapies remain a standard approach in vestibular migraine management.
guidelinesupported- PMID
- 43010986
- DOI
- 10.3389/fneur.2026.1951810.
- Journal
- Frontiers in Neurology
- Publication type
- systematic_review
- Evidence level
- 1a
- Population
- Patients diagnosed with vestibular migraine across included studies
- Intervention
- Conventional therapies and CGRP-targeted therapies for vestibular migraine
- Comparator
- Conventional (non-CGRP) pharmacological and non-pharmacological treatments
Primary outcomes
Diagnostic accuracy and criteria for vestibular migraine; Efficacy of conventional treatments; Efficacy and safety of CGRP-targeted therapies